Piper Jaffray adds Amylin Pharmaceuticals (Nasdaq: AMLN) to its Alpha List, citing updates over the next 90 days that should ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE